Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Special Report Awards Gala Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Subscribe Pharma Vaccines Asia Cell & Gene Therapy Drug Delivery Executives Manufacturing Facilities Recalls Warning Letters Marketing Special Reports Fierce 50 Special Report Awards Gala Resources Podcasts Fierce Events Industry Events Webinars Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Stories Sponsored In boost to GSK's £3B plan for Blenrep, myeloma ADC shows survival edge over J&J's Darzalex The head-to-head overall survival win makes GSK’s £3 billion peak sales goal for the multiple myeloma antibody-drug conjugate look more attainable. Sponsored Leveraging Science to Unlock Progress in Advanced Prostate Cancer Ongoing scientific research is needed to better understand prostate cancer and identify treatment options to help address unmet needs of patients.
Sponsored In boost to GSK's £3B plan for Blenrep, myeloma ADC shows survival edge over J&J's Darzalex The head-to-head overall survival win makes GSK’s £3 billion peak sales goal for the multiple myeloma antibody-drug conjugate look more attainable.
Sponsored Leveraging Science to Unlock Progress in Advanced Prostate Cancer Ongoing scientific research is needed to better understand prostate cancer and identify treatment options to help address unmet needs of patients.
